Considering the broad role of neurotrophins, including supportive and neuroprotective activity, triazinetrione-based positive allosteric modulators of Trk receptors may also have an additional upside of achieving disease-modifying effects in neurodegenerative disorders like AD or PD. The gene discussed is BDNF; the disease is Alzheimer disease.